Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Stockholders' Equity (Deficit)	Common Stock	Treasury Stock, at Cost	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss), Net	Noncontrolling Interest
Beginning balance (in shares) at Jan. 29, 2023			63,870,581
Beginning balance at Jan. 29, 2023	$ 756,035	$ 755,852	$ 785	$ (577,907)	$ 471,374	$ 858,240	$ 3,360	$ 183
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(449,672)	(449,667)				(449,667)		(5)
Other comprehensive income (loss)	2,097	2,097					2,097
Share-based compensation	31,455	31,455			31,455
Treasury stock reissued (in shares)			414,179
Treasury stock reissued to settle share-based awards	(5,476)	(5,476)		17,013	(22,489)
Ending balance (in shares) at Oct. 29, 2023			64,284,760
Ending balance at Oct. 29, 2023	334,439	334,261	$ 785	(560,894)	480,340	408,573	5,457	178
Beginning balance (in shares) at Jul. 30, 2023			64,030,212
Beginning balance at Jul. 30, 2023	367,015	366,835	$ 785	(572,990)	486,365	446,823	5,852	180
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(38,252)	(38,250)				(38,250)		(2)
Other comprehensive income (loss)	(395)	(395)					(395)
Share-based compensation	9,132	9,132			9,132
Treasury stock reissued (in shares)			254,548
Treasury stock reissued to settle share-based awards	(3,061)	(3,061)		12,096	(15,157)
Ending balance (in shares) at Oct. 29, 2023			64,284,760
Ending balance at Oct. 29, 2023	$ 334,439	334,261	$ 785	(560,894)	480,340	408,573	5,457	178
Beginning balance (in shares) at Jan. 28, 2024	64,415,861		64,415,861
Beginning balance at Jan. 28, 2024	$ (307,250)	(307,434)	$ 785	(556,888)	485,452	(233,790)	(2,993)	184
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(201,040)	(201,040)				(201,040)
Other comprehensive income (loss)	(3,208)	(3,208)					(3,208)
Distribution to outside interest upon liquidation of a consolidated subsidiary	(184)							(184)
Issuance of common stock upon exchange of 2028 Notes (as defined in Note 9) (in shares)			10,378,431
Issuance of common stock upon exchange of 2028 Notes (as defined in Note 9)	333,255	333,255	$ 100		333,155
Share-based compensation	44,792	44,792			44,792
Treasury stock reissued (in shares)			607,547
Treasury stock reissued to settle share-based awards	$ (6,049)	(6,049)		20,597	(26,646)
Ending balance (in shares) at Oct. 27, 2024	75,401,839		75,401,839
Ending balance at Oct. 27, 2024	$ (139,684)	(139,684)	$ 885	(536,291)	836,753	(434,830)	(6,201)	0
Beginning balance (in shares) at Jul. 28, 2024			75,118,173
Beginning balance at Jul. 28, 2024	(141,437)	(141,437)	$ 885	(548,619)	836,271	(427,244)	(2,730)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,586)	(7,586)				(7,586)
Other comprehensive income (loss)	(3,471)	(3,471)					(3,471)
Share-based compensation	15,317	15,317			15,317
Treasury stock reissued (in shares)			283,666
Treasury stock reissued to settle share-based awards	$ (2,507)	(2,507)		12,328	(14,835)
Ending balance (in shares) at Oct. 27, 2024	75,401,839		75,401,839
Ending balance at Oct. 27, 2024	$ (139,684)	$ (139,684)	$ 885	$ (536,291)	$ 836,753	$ (434,830)	$ (6,201)	$ 0